CIK 0000715446
- Non-accelerated filer
- Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 112622630
- Phone
- +1 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
- 4 Exercise or conversion Vice President - Finance & CFO acquired 200,000 shares (option exercise)
- 4 Exercise or conversion Chief Executive Officer acquired 1,000,000 shares (option exercise)
- 5 Insider Annual Insider Trading Report
- 4 Open-market sale President sold 1,785,905 shares at an average $0.56 ($1,005,318)
- 4 Exercise or conversion President acquired 550,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion President acquired 600,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
- 4 Grant or award Chief Executive Officer acquired 120,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale VP-Finance & CFO sold 15,000 shares at $0.80 ($12,000)
- 5 Insider Annual Insider Trading Report
Page 22 of 24 · 471 filings